Yan‐yan Yan

808 citations
14 papers · 655 indexed · h-index 13
Topics
Drug Transport and Resistance Mechanisms (7 papers)Cancer therapeutics and mechanisms (5 papers)HIV/AIDS drug development and treatment (3 papers)

In The Last Decade

Yan‐yan Yan

14 papers receiving 638 citations

Peers

Yan‐yan Yan
Comparison fields: 5 of 79
  • Molecular Biology 356
  • Oncology 303
  • Cancer Research 91
  • Pharmacology 73
  • Infectious Diseases 68
Replace Li-Sheng Zheng with:
Li-Sheng Zheng China
Yuki Nakajima Japan
Yue-Li Sun China
Naif A. Al-Jomah Saudi Arabia
Haijun Yu China
Alex Starr Israel
Nguyen T. Van United States
Jung-Chen Su Taiwan
Marianna G. Yakubovskaya Russia
Yan‐yan Yan relative to Li-Sheng Zheng China Li-Sheng Zheng's profile →
Citations per field
00.5×1.5×2.4×
Li-Sheng Zheng · 1×
Citations per year

Countries citing papers authored by Yan‐yan Yan

Since Specialization
Citations

This map shows the geographic impact of Yan‐yan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐yan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐yan Yan more than expected).

Fields of papers citing papers by Yan‐yan Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐yan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐yan Yan. The network helps show where Yan‐yan Yan may publish in the future.

Co-authorship network of co-authors of Yan‐yan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐yan Yan. A scholar is included among the top collaborators of Yan‐yan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐yan Yan. Yan‐yan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 80
2 26
3 56
4 10
5 18
6 45
7 12
8 44
9 85
10 101
11 75
12
Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
21
13 69
14 13

About Yan‐yan Yan

Yan‐yan Yan is a scholar working on Oncology, Infectious Diseases and Molecular Biology, having authored 14 papers that have together received 655 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (5 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Oncology (303 citations), Toxicology (26 citations) and Cancer Research (91 citations). Yan‐yan Yan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Liwu Fu, Yong‐ju Liang, Chun-ling Dai, Jianye Zhang, Fang Wang, Zhi‐Gang She, Liming Chen, Zhe‐Sheng Chen, Amit K. Tiwari and Li-Sheng Zheng. Their work appears in journals such as PLoS ONE, European Journal of Cancer and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026